State Key Laboratory for Mechanical Behavior of Materials, Xi'an Jiaotong University , Xi'an 710049, China.
ACS Appl Mater Interfaces. 2017 Mar 22;9(11):9449-9461. doi: 10.1021/acsami.7b00322. Epub 2017 Mar 8.
Novel films on Ti-based orthopedic implants for localized antimicrobial delivery, which comprises dual-diameter TiO nanotubes with the inner layers of compact and fluorine-free oxide tightly bonding to Ti, were formed by voltage-increased anodization with F sedimentation procedure. The nanotubes were closely aligned and structured with upper 35 and 70 nm diametric tubes as nanocaps, respectively, and the underlying 140 nm diametric tubes as nanoreservoirs. Followed by loading ponericin G1 (a kind of antimicrobial peptide (AMP)) into the dual-diameter nanotubes with vacuum-assisted physisorption, the resultant films were investigated for loading efficiency and release kinetics of AMP, antibacterial activity against Staphylococcus aureus, and osteoblastic compatibility, together with the AMP-loaded single-diameter (140 nm) nanotube film. The loaded films had no statistical difference in the loading efficiency of AMP and revealed burst release within 6 h followed by steady release of AMP in phosphate-buffered solution. At day 42, almost all of AMP was released from the single-diameter nanotube film. However, the dual-diameter nanotube films loaded with AMP still showed sustained release at least up to 60 days, and the sustained efficacy was enhanced with decreasing diameter of nanocaps. In the case of nominal AMP loading amount of 125 μg, the resultant 35 nm capped dual-diameter nanotube film exhibited significant short- and long-term (even for 49 days) antibacterial activity not only against planktonic bacteria, which is ascribed to the release-killing efficacy of AMP, but also against adhered bacteria, which is ascribed to the AMP-derived killing efficacy and the nanocaps-derived adhesion resistance. Moreover, this loaded film presented cytocompatibility comparative to that of Ti but higher than that of the other AMP-loaded films. Increasing the nominal loading amount of AMP to 200 μg improved antibacterial activity but gave rise to obvious cytotoxicity of the loaded films.
新型基于 Ti 的骨科植入物局部抗菌药物输送的薄膜,通过电压升高阳极氧化和 F 沉淀程序形成,其特征在于具有紧密结合的 Ti 的内致密层和无氟氧化物的双直径 TiO 纳米管。纳米管紧密排列且结构一致,上层 35 和 70nm 直径的纳米管分别作为纳米胶囊,底层 140nm 直径的纳米管作为纳米储库。随后通过真空辅助物理吸附将粘菌素 G1(一种抗菌肽 (AMP))加载到双直径纳米管中,研究了 AMP 的负载效率和释放动力学、对金黄色葡萄球菌的抗菌活性以及成骨细胞相容性,同时研究了 AMP 负载的单直径(140nm)纳米管薄膜。负载的薄膜在 AMP 的负载效率上没有统计学差异,在磷酸盐缓冲溶液中在 6 小时内呈现爆发释放,随后是 AMP 的稳定释放。在第 42 天,几乎所有的 AMP 都从单直径纳米管薄膜中释放出来。然而,负载 AMP 的双直径纳米管薄膜至少在 60 天内仍显示持续释放,并且随着纳米胶囊直径的减小,持续效果增强。在名义 AMP 负载量为 125μg 的情况下,所得的 35nm 盖帽双直径纳米管薄膜不仅对浮游菌显示出显著的短期和长期(甚至 49 天)抗菌活性,这归因于 AMP 的释放杀伤效果,而且对粘附菌显示出显著的短期和长期(甚至 49 天)抗菌活性,这归因于 AMP 衍生的杀伤效果和纳米胶囊衍生的粘附阻力。此外,该负载薄膜表现出与 Ti 相当的细胞相容性,但高于其他负载 AMP 的薄膜。将 AMP 的名义负载量增加到 200μg 提高了抗菌活性,但导致负载薄膜的明显细胞毒性。